On Jan. 07, Siegall Clay B divested U.S. $5,061,681 in shares of Seagen Inc.. The Pres, CEO sold 29,353 shares at a price per share of $172.44. The transaction decreased this specific insider’s holdings to 715,209 shares worth around $127.06 million at present.
Stifel maintained its Seagen Inc. [SGEN] rating to the equivalent of a Hold but changed the price target to $165 from $145, in a research note dated September 22, 2020. That figure represents around a -7.67% premium from where the company’s shares closed on Friday. Other analysts also revised their coverage, with Stifel’s analysts reiterating the shares to “a Hold” rating in a research note to investors issued in late September. In addition, there was no change from H.C. Wainwright on July 31, 2020. The rater maintained SGEN to “a Buy” but assigned new target price of $200.
Is Seagen Inc. [NASDAQ:SGEN] a Good Buy Right Now?
It should be noted that SGEN technical indicators for short, intermediate as well as long term progress have placed an overall average of 40% as Buy. The average signal changed from 48% Buy in the last week and compares with 40% Buy in the past month. Data from Seagen Inc.’s Trend Spotter indicated that the signals were Weakest. The stock current average is 1.02 million shares in the past 20 days and the short term average signal indicates a 50% Buy. In the last 50 days, the average trading volume was 1.0 million shares while the medium term average advocated for 50% Buy. The average long-term signal stands at 50% Buy and the 100-day average volume stands at 0.95 million shares.
SGEN Price Performance
On Wall Street, Seagen Inc. [NASDAQ:SGEN] finished Friday’s session up 0.74% at $177.66. The stock went up to $180.46 at the same session while its lowest single day price was $174.8101. In the last five days, it saw a rise of about 1.44%, Seagen Inc. shares gained by almost 1.44% since the beginning of the year. However, the share price has dropped to as low as -16.96% below its one year high. On 01/08/21, the company shares recorded $180.46, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/06/21, the same year at $165.69. The company’s shares have inclined by 58.87% in the past year. The 50-day SMA achieved is $179.61 while the 200-day SMA is $166.79. Volume dropped to 0.89 million from 1.21 million in the previous session.
Seagen Inc. [SGEN] Valuation Measures
Notably, Seagen Inc. [SGEN] stock cannot be classified as a good candidate in the listing of underestimated low-priced Biotechnology companies to purchase soonest possible with the prevailing 12-month PE ratio of 69.70. The measure means the stock is exchanging at a premium as compared to the 41.16x trailing earnings of the industry. It can be helpful for investors to consider historical price-sales ratio, more specifically, a 17.06 PS value ratio is reported for the last one year of reported earnings. That is lower than the industry average of 20.67 which means SGEN serve an unattractive investment opportunity compared to its competitors.
SGEN Stock Support And Resistance Levels
On the 24-hour scale, the immediate backing is perceived around 174.83 level, and in case of violation of this particular level, it will cause more drop to 171.99 level. On the upper level, 183.29 is still the key resistance. The stock may increase to the subsequent resistance at 180.48. The Relative Strength Index (RSI) pinned on the 14-day chart is 45.58, implying a neutral technical stance while the MACD stands at -9.75, meaning price will decrease in the next trading period. Percent R indicator moved to 67.57%, implying low price movement. Stochastic %K at 21.40% suggest holding the stock.
What is the short interest in Seagen Inc.?
Short interest in the Seagen Inc. stock has plunged, decreasing by -0.71 million shares to total 4.39 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 3.68 million, data from Yahoo Finance shows. The increase of 16.17% suggests the stock saw some increased bearish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 7.26% of the overall float for the stock.
Seagen Inc.’s Biggest Shareholders: Who Owns Seagen Inc. [SGEN]?
Filings by Baker Bros. Advisors LP showed that the firm now holds a total of 47,269,424 shares or roughly 26.22% of the outstanding SGEN shares. This means their shares have reduced by 0 from the 47,269,424 the investor reportedly held in its prior 13-F filing. With the conclusion of the sale, Capital Research & Management Co updated stake is worth $3,173,948,934. Details in the latest 13F filings reveal that The Vanguard Group, Inc. disposed off their -2.30% stake valued at $1,801,846,590 while T. Rowe Price Associates, Inc. cut theirs at $1,522,224,308. During the last quarter, The Vanguard Group, Inc. liquidated -249,584 of its shares in Seagen Inc. while T. Rowe Price Associates, Inc. sold -276,166 shares. The BlackRock Fund Advisors’s holdings currently number 6,853,836 shares at $1217652503.76. According to the firm’s last 13F report, PRIMECAP Management Co. shares in the company at filing stood at 5,750,582 shares, roughly $979,381,620.
SGEN Earnings Forecast For The Current Quarter
Seagen Inc. [SGEN] is expected to report strong earnings results for the quarter ending on Dec 2020. Consensus estimates give the company expected revenues of $583.22M and an earnings per share of $0.87 for Dec 2020. Looking further ahead, the company is expected to report revenue of $377M at an EPS of -$0.27 for Mar 2021. The estimates represent upside of -16.80% and -97.63% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.
SGEN Earnings Estimates For The Current Year
For the financial year, Seagen Inc. [NASDAQ:SGEN] is expected to bring in revenue of $2.16B. The returns are nearly $1.24 billion higher than the company’s actual revenue recorded in the fiscal year 2019. In terms of EPS for the 2020, estimate put it at 3.29, higher than that of FY19 by $4.25. Estimates put this year’s earnings growth at 442.70%, -97.60% for the next, and at an annual 236.60% over the next 5-year period. As for sales, forecasts are for an increase of 135.30% in the current fiscal year and a further -16.80% over the following year.
What are analyst thoughts on Seagen Inc.?
Looking forward to the Seagen Inc. share price prediction, we can see that analysts, surveyed by FactSet, offer the mean price target for Seagen Inc. stock at $200.00 within the next 12 months, which represents almost 11.17 per cent growth from its previous closing price of $177.66. The highest analysts’ target for Seagen Inc. stock projections is $254.00 and the lowest one is $165.00. Still, 19 analysts sharing their consensus rating for SGEN stock in 2021 agree that it is an Overweight.